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the borderline range of 13 mm” was in error. Six percent had a
wall thickness of14 mm as stated in the caption of Figure 2. The
incidence of intraventicular septal thickness of more than 13 mm
(14 to 16 mm) was 11% (17 of 156 subjects) as stated in the Results
section. The incidence of either the intraventricular septal wall or
left ventricular free wall being more than 13 mm was actually
higher (13%; 20 of 156 subjects).
The findings presented in our study demonstrate the chamber
size, wall thickness, and ejection fraction of elite professional
American football players in the NFL. Because both the size and
the types of physical effort of these players are different from those
of bodybuilders, rowers, canoists, or cyclists, we believe these
observations will be useful in separating physiologic adaptations
from pathologic findings when evaluating such players.
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Cellular Myocardial
Reconstruction Using Human Myoblasts
The Expedited Review from Pagani et al. (1) and the Research
Letter from Hagege et al. in The Lancet (2) are the first reports that
provide evidence about the fate of human myoblasts posttransplan-
tation. Before these reports appeared there was no histological
evidence on the viability and in vivo behavior of the human
myoblasts after engraftment into the myocardium. These are
significant findings and may provide clues to the unanswered
questions impeding the progress in heart cell therapy using
myoblasts. Moreover, these reports will provide impetus to the
efforts in defining the basic mechanism underlying cardiac function
improvement in postmyoblast transplantation.
Pagani et al. (1) showed that transplanted myoblasts developed
into myotubes and expressed human myosin heavy chain (slow
isoform) in the myocardium. The myofibers originating from the
myoblasts aligned in accordance with the heart muscle architec-
ture. These results may resolve the controversy surrounding the
milieu-dependent trans-differentiation of myoblasts into cardio-
myocytes. The absence of connexin-43 expression, however, con-
firms the lack of electrical integration between the skeletal myo-
fibers and the surrounding cardiac tissue. Without such linkage, it
will be difficult for the cell graft to synchronize its contractility with
the myocardium.
Considering the difficulties of using human subjects as a model,
we developed a porcine heart model of myocardial infarction with
immune tolerance in order to study the in vivo behavior of the
human myobalsts and to define the underlying mechanism of
global improvement in the left ventricular pump function. We
observed the persistence of lac-z reporter gene carrying human
myoblasts for up to seven months in the porcine heart (3). The
xenografted myoblasts expressed human skeletal muscle myosin
heavy chain (slow isoform) at the site of transplantation. Similar to
the results obtained by Pagani et al. (1), we observed that the cells
followed the geometric organization of the host tissue. An inter-
esting finding of our study—based on histochemistry and fluores-
cent in situ hybridization analysis using a cocktail of probes specific
for human and porcine chromosomes—is the presence of hetero-
karyons in the host myocardium resulting from the fusion between
the donor myoblasts and the recipient cardiomyocytes. This
hypothesis is substantiated by the long-term survival of the
xenograft even after the discontinuation of immunosuppression
(3). The observation of myofibers expressing both slow and fast
isoforms of myosin by Hagege et al. (2) may be due to spontaneous
fusion between myoblasts and the cardiomyocytes. We believe that
together with other proposed mechanisms, formation of mosaic
muscle fibers is the underlying mechanism in the improvement of
cardiac function.
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